⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thioglycin SCHEMBL29548409 | 0.95 | — | — | |
| Hydrogen Peroxide SCHEMBL4288872 | 0.72 | — | — | |
| SCHEMBL8377216 | 0.70 | — | — | |
| SCHEMBL608733 | 0.70 | — | — | |
| SCHEMBL475159 | 0.70 | — | — | |
| Glycine SCHEMBL22206093 | 0.68 | — | — | |
| Bromide SCHEMBL10873565 | 0.67 | — | — | |
| SCHEMBL5144336 | 0.67 | — | — | |
| SCHEMBL8712166 | 0.67 | — | — | |
| Ethylenediamine SCHEMBL3360101 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024126977-A1 | HYDROGEN SULPHIDE (H2S) GENERATING COMPOUNDS FOR USE IN THE TREATMENT OF PREECLAMPSIA AND RELATED DISORDERS IN OBESE PREGNANT WOMEN | MIRZYME THERAPEUTICS LIMITED (GB) | 2024-06-20 | — | — | WO | claimed |
| CN-116848205-A | Polishing slurry composition | 凯斯科技股份有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-114010648-A | Use of H2S producing compounds for the treatment of preeclampsia or fetal growth restriction | 米尔酶治疗有限公司 | 2022-02-08 | — | — | CN | claimed |
| EP-2673000-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | Wu, Nian (US) | 2013-12-18 | — | — | EP | claimed |
| EP-2456424-B1 | OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM | GRUENENTHAL GMBH (DE) | 2013-08-28 | — | — | EP | claimed |
| WO-2012109112-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | claimed |
| WO-2012109052-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | claimed |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPOSEUTICALS, INC. | 2012-08-09 | — | — | US | claimed |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-09 | — | — | US | claimed |
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2010-03-25 | — | — | US | claimed |
| EP-1828175-A2 | PROCESS FOR OBTAINING ENANTIOMERS OF THIENYLAZOLYLALCOXYETHANAMINES | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-09-05 | — | — | EP | claimed |
| WO-2006063860-A2 | PROCESS FOR OBTAINING ENANTIOMERS OF THIENYLAZOLYLALCOXYETHANAMINES | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-06-22 | — | — | WO | claimed |
| EP-4746860-A1 | HYDROGEN SULPHIDE FOR TOPICAL TREATMENT OF NAIL INFECTION | KING'S COLLEGE LONDON (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-12467053-B2 | Hybrid immunoglobulins with moving parts | BIOMOLECULAR HOLDINGS LLC (US) | 2025-11-11 | — | — | US | disclosed |
| WO-2025137256-A1 | POLYOXAZOLINE-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-120077059-A | IL-15 prodrugs and uses thereof | 舒泰神(加州)生物科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| EP-0014633-A2 | Process for preparing an ultrasonographic image | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1980-08-20 | — | — | EP | disclosed |
| US-4169834-A | RIFAMYCIN DERIVATIVES | GRUPPO LEPETIT S.P.A. (IT) | 1979-10-02 | — | — | US | disclosed |
| US-4146395-A | POISONING FIRST SILVER IMAGE, REVERSE SILVER IMAGE PATTERN USED AS REDOX CATALYST | EASTMAN KODAK COMPANY (US) | 1979-03-27 | — | — | US | disclosed |
| US-4089685-A | DEVELOPING SILVER IMAGE FROM EXPOSED SILVER HALIDE PHOTOGRAPHIC ELEMENT, POISIONING, REDUCTION | EASTMAN KODAK COMPANY (US) | 1978-05-16 | — | — | US | disclosed |